News | April 28, 2008

Science Channel Features InnerCool’s Endovascular Cooling During Brain Surgery

April 29, 2008 - Cardium Therapeutics and its operating unit InnerCool Therapies said today that InnerCool’s endovascular Celsius Control System was featured on Science Channel’s “Cool Stuff: How It Works.”

The segment (episode 5) aired April 25, 2008, and is scheduled to be rebroadcast at 8:30 p.m. and 11:30 p.m. (ET/PT) on Friday, May 9.

The episode featured InnerCool’s Celsius Control endovascular system during a six-hour brain surgery at Stanford University School of Medicine in Palo Alto, CA, during the surgery Dr. Gary K. Steinberg and his surgical team cooled a patient.

“Although the precise mechanism of mild cooling’s protective effect on the brain is unclear, it appears to blunt the detrimental cascade of events at the cellular level that occurs during the minutes, hours, and sometimes even days after an adverse neurologic event,” said Dr. Steinberg, Lacroute-Hearst professor and chairman of the Standford Department of Neurosurgery. “Hypothermia therapy is increasingly being used for neuroprotection during neurovascular surgery to improve neurologic function and decrease disability.”

Dr. Steinberg has been using therapeutic hypothermia in the clinic since 1991. He has used it in more than 2,500 patients with cerebrovascular problems to minimize the high risk of stroke and ischemic brain damage.

Patient temperature modulation is a rapidly-advancing field focused on preserving ischemic tissue and improving patient outcomes following major medical events such as stroke, cardiac arrest and heart attack, as well as in the management of patients experiencing trauma or fever. Temperature modulation is intended to cool patients in order to reduce cell death and damage caused by ischemic events in which blood flow to critical organs such as the heart or brain is restricted, and to prevent or reduce associated injuries such as adverse neurologic outcomes.

InnerCool’s endovascular approach to patient temperature modulation is based on a single-use, flexible, metallic catheter and a cooling system that allows for rapid and controlled cooling and rewarming. It integrates a slim catheter profile, a highly efficient flexible metallic thermal transfer element, a built-in temperature monitoring sensor, and a programmable console capable of rapidly inducing, maintaining and reversing therapeutic cooling.

InnerCool’s next generation RapidBlue system for high-performance endovascular temperature modulation is expected to receive FDA clearance in the second quarter 2008. The RapidBlue system includes a programmable console with an enhanced user interface and a catheter designed to quickly modulate patient temperature in association with surgery or other medical procedures.

For more information:,

Related Content

therapeutic hypothermia, children, cardiac arrest, treatment, temperature
Feature | May 04, 2015
A large-scale, multicenter study has shown that therapeutic hypothermia does not improve survival rates or reduce brain...
News | December 11, 2014
Researchers at Okayama University in collaboration with several medical centers in Japan have demonstrated the safety...
Feature | September 19, 2014
September 19, 2014 — According to a new study, peritoneal hypothermia is feasible for patients who have suffered ST-...
Technology | July 10, 2014
July 10, 2014 — Life Recovery Systems announced the U.S. Food and Drug Administration (FDA) has approved two...
therapeutic hypothermia, Philips InnerCool

The Philips InnerCool RTx system was used in the CHILL-MI study for use in STEMI patients.

Feature | February 03, 2014 | Dave Fornell
Use of therapeutic hypothermia is used to prevent neurological damage in patients who suffer sudden cardiac arrest (SCA...
BeneChill RhinoChill Therapeutic Hypothermia Cath Lab Intranasal Cooling System
News | January 22, 2014
BeneChill Inc. received the 2014 Frost & Sullivan Award for Technology Innovation Leadership for its RhinoChill...
rhinochill, RhinoChill, benechill, BeneChill

RhinoChill IntraNasal Cooling System

News | December 03, 2013
With the benefits of conventional strategies for therapeutic hypothermia following cardiac arrest being called in to ...
therapeutic hypothermia temperature management cath lab clinical trial study
Feature | November 01, 2013
clinical trial shows that rapidly cooling...
News | October 01, 2013
The Cardiovascular Research Foundation (CRF) announced the late breaking trials and first report investigations that...
News | August 06, 2013
Vanderbilt Heart and Vascular Institute is participating in the VELOCITY study, a randomized controlled clinical study...
Overlay Init